[Control of hematologic adverse effects of antineoplastic drugs].
Wiktor-Jedrzejczak
W
W
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001772:Blood Cell Count; D006400:Hematocrit; D006402:Hematologic Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D008991:Monitoring, Physiologic; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D009894:Opportunistic Infections / Q000209:etiology / Q000517:prevention & control*; D018805:Sepsis / Q000517:prevention & control; D014115:Toxemia / Q000209:etiology / Q000517:prevention & control*
D000970:Antineoplastic Agents
Zwalczanie hematologicznych skutków działań niepozadanych leków przeciwnowotworowych.